Skip to main content
Department of Neurology

Department of Neurology

News releases

September 2015arrow

UC Davis to hold annual Spanish-language Mini Medical School

September 1, 2015

UC Davis Health System will host its annual Mini-Medical School in Spanish, La Mini Escuela de Medicina en Español, on Saturday, Sept. 12 on the Sacramento campus of UC Davis. The event is sponsored by the Alzheimer’s Disease Center, Center for Reducing Health Disparities and the Latino Aging Research Resource Center of UC Davis. [en español]

August 2015arrow

UC Davis researchers receive $5.4 million grant to study new tool to evaluate early-stage Alzheimer's

August 31, 2015

Alzheimer’s researchers at UC Davis and UC San Diego have launched a new study which aims to detect the earliest stages of cognitive dysfunction in people with pre-clinical Alzheimer’s disease by using event-related brain potentials (ERPs).

UC Davis ALS Multidisciplinary Clinic takes up the ALS ice-bucket challenge

August 18, 2015

Hardy souls from the UC Davis Multidisciplinary ALS Clinic will take up the cause to raise funds for the ALS Association on Wednesday, Aug. 19, during the ALS ice-bucket challenge — a dousing with ice-cold water that is a call to action to donate to a cure for ALS.

July 2015arrow

UC Davis offers stroke-prevention alternative for patients with atrial fibrillation

July 29, 2015

Cardiologists at UC Davis are the first in Northern California to treat the major risk of stroke that comes with atrial fibrillation (AF), the most common form of arrhythmia, with a device that blocks blood clots from traveling from the heart to the head.

One of America's top hospitals

July 21, 2015

UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report.

UC Davis Alzheimer's researchers at core of leading-edge dementia discoveries

July 16, 2015

Imaging the brain, collecting clinical measurements and biological specimens, and generating an unprecedented volume of data for more than 1,700 participants, the groundbreaking Alzheimer's Disease Neuroimaging Initiative (ADNI) has painted a detailed picture of the brain’s progression from cognitive impairment to Alzheimer’s disease, often over many years, demonstrating that while amyloid brain deposits are a leading factor in dementia, there is considerable heterogeneity in cognitive decline in aging.

Lecture to address reducing the risk of falls and related injuries among the elderly

July 14, 2015

Falls, the leading cause of non-fatal and fatal injuries and a leading cause of death among the elderly, will be the topic of the July UC Davis Alzheimer’s Disease Center Community Discovery Series lecture. The speaker will be Christy Adams, UC Davis Health System Trauma Prevention and Outreach Program coordinator.

Rogawski receives 2015 Neuroendocrine Research Award from the American Academy of Neurology

July 9, 2015

Michael Rogawski, professor of neurology at UC Davis, recently was awarded the 2015 Neuroendocrine Research Award at the 67th Annual American Academy of Neurology meeting in Washington, D.C.

June 2015arrow

UC Davis awards $1 million for brain research

June 24, 2015

UC Davis is stimulating innovative, collaborative brain research with a new program offering funding for projects with strong potential to lead to impactful discoveries.

May 2015arrow

UC Davis tests deep brain stimulation as a treatment for cognitive changes in Parkinson's

May 12, 2015

Surgeons at UC Davis Health System are testing an innovative method of limiting cognitive decline in patients with Parkinson’s disease. The treatment — deep brain stimulation, or DBS — involves delivering low levels of electrical stimulation to a part of the brain that controls the abilities to think, plan and remember.

Drug, Device Discovery and Development initiative moves forward

May 11, 2015

On April 15, 2015, three UC Davis leaders in research joined more than forty scientists from across the University of California (UC) system and representatives from the biomedical industry to discuss plans for strengthening UC’s position in drug, device and diagnostics development. 

April 2015arrow

UC Davis makes breakthrough in understanding Canavan disease

April 27, 2015

UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations of Semitic descent, particularly families from Saudi Arabia.

UC Davis Alzheimer's Disease Center opens new clinic in Walnut Creek

April 16, 2015

The UC Davis Alzheimer's Disease Center, one of only 27 research centers designated by the National Institutes of Health's National Institute on Aging, has established a new clinic in the East Bay in Walnut Creek.

UC Davis Alzheimer's Disease Center looks at Building a Better Brain as We Age

April 15, 2015

David A. Bennett, director of the Rush University Alzheimer's Disease Center, will discuss "Reducing Your Risk for Alzheimer's Disease: Building a Better Brain as We Age," during the May UC Davis Alzheimer's Disease Center Community Engagement Lecture Series presentation.

March 2015arrow

UC Davis receives $10 million grant to establish center to study schizophrenia

March 26, 2015

UC Davis will establish a prestigious, leading-edge center to advance innovative research into the origins of schizophrenia: A Silvio O. Conte Center for Basic or Translational Mental-Health Research, one of only 15 such centers in the United States.

Alzheimer's Disease Center lecture explores connections between diabetes, heart disease and dementia

March 18, 2015

"Heart Disease, Diabetes and Dementia, What is the Connection?" will be the topic of the UC Davis Alzheimer's Disease Center 2015 Community Discovery lecture by center Associate Director Bruce Reed.

Commentary says study affirms that varied factors contribute to cognitive decline throughout adulthood

March 16, 2015

A study published online today in JAMA Neurology that finds associations between reduced hippocampal volume (HVa) and being male, but not the gene APOE ɛ4, suggests that there are multiple factors contributing to cognitive decline throughout adulthood, according to an accompanying commentary by UC Davis Alzheimer's Disease Center Director Charles DeCarli.

UC Davis scientists describe novel drug mechanism that fights brain cancer

March 3, 2015

Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers.

February 2015arrow

UC Davis Huntington's Disease Center receives Level 1 designation

February 27, 2015

The UC Davis Huntington’s Disease Center, whose compassionate patient care and research expertise have made it a beacon of hope for people with Huntington’s disease throughout Northern California and beyond, has been acknowledged by the national society committed to the values that it so ably upholds  the Huntington’s Disease Society of America — as a Level 1 Huntington’s Disease Center of Excellence.

UC Davis researchers identify new compound that takes aim at neuropathic pain

February 10, 2015

A new compound discovered by a team of UC Davis investigators has potent actions against production of a chemical that is implicated in the development of chronic pain following a peripheral nerve injury in the spinal cord.

December 2014arrow

Perceptions, referrals by medical providers affect mental-health treatment disparities

December 1, 2014

Disparities in mental-health treatment are known to be associated with patients’ racial and ethnic backgrounds. Now, a large study by researchers with UC Davis has found one possible reason for those disparities: Racial and ethnic minorities are less likely to be assessed and referred for treatment by their medical providers.

November 2014arrow

UC Davis investigational medication used to resolve life-threatening seizures in children

November 12, 2014

In its first clinical application in pediatric patients, an investigational medication developed and manufactured at UC Davis has been found to effectively treat children with life-threatening and difficult-to-control epileptic seizures without side effects, according to a research report by scientists at UC Davis and Northwestern University.

October 2014arrow

UC Davis MIND Institute researchers to establish new tests to evaluate cognitive growth in people with intellectual disability

October 30, 2014

Researchers with the UC Davis MIND Institute will develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess accurately: those with an intellectual disability, formerly termed mental retardation. The research will be funded through a new, five-year, $3.2 million grant from the National Institutes of Health (NIH).

Kay Redfield Jamison to discuss Professional and Personal Perspectives on Bipolar Illness

October 27, 2014

Kay Redfield Jamison, Dalio Family Professor in Mood Disorders and co-director of the Mood Disorders Center at the Johns Hopkins School of Medicine, will discuss "Professional and Personal Perspectives on Bipolar Illness," during a lecture on Thursday, Nov. 6, at 5 p.m. in the auditorium of the UC Davis MIND Institute, 2825 50th St.

UC Davis Alzheimer's Disease Center holds workshop for Alzheimer's caregivers

October 20, 2014

The UC Davis Alzheimer’s Disease Center will hold a workshop for those caring for individuals with Alzheimer’s disease and dementia. The workshop will be held from 8 a.m. to 12:30 p.m. Saturday, Nov. 15, in the auditorium of the UC Davis MIND Institute, 2825 50th St., Sacramento. There is no cost to participate in the workshop; however, reservations are required to attend.